These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20206893)

  • 1. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.
    Shah DD; Fonarow GC; Horwich TB
    J Card Fail; 2010 Mar; 16(3):200-6. PubMed ID: 20206893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
    Giamouzis G; Triposkiadis F; Butler J
    J Card Fail; 2010 Mar; 16(3):207-10. PubMed ID: 20206894
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of new-onset diabetes mellitus and glycemic control on the prognosis of heart failure patients: a propensity-matched study in the community.
    Romero SP; Garcia-Egido A; Escobar MA; Andrey JL; Corzo R; Perez V; Garcia-Domiguez GJ; Gomez F
    Int J Cardiol; 2013 Aug; 167(4):1206-16. PubMed ID: 22560913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.
    McAlister FA; Eurich DT; Majumdar SR; Johnson JA
    Eur J Heart Fail; 2008 Jul; 10(7):703-8. PubMed ID: 18571471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure.
    Egstrup M; Kistorp CN; Schou M; Høfsten DE; Møller JE; Tuxen CD; Gustafsson I
    Eur Heart J Cardiovasc Imaging; 2013 Apr; 14(4):349-57. PubMed ID: 22898711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community.
    Romero SP; Andrey JL; Garcia-Egido A; Escobar MA; Perez V; Corzo R; Garcia-Domiguez GJ; Gomez F
    Int J Cardiol; 2013 Jun; 166(2):404-12. PubMed ID: 22112681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of adaptive servo-ventilation in patients with severe systolic heart failure.
    Takama N; Kurabayashi M
    J Cardiol; 2014 Apr; 63(4):302-7. PubMed ID: 24373869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: Results of the observational community-based EPICAL cohort study.
    Agrinier N; Thilly N; Briançon S; Juillière Y; Mertes PM; Villemot JP; Alla F; Zannad F;
    Int J Cardiol; 2017 Feb; 228():940-947. PubMed ID: 27912203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort.
    Yeh JK; Hsiao YC; Jian CR; Wang CH; Wen MS; Kuo CT; Tsai FC; Wu VC; Chen TH
    PLoS One; 2016; 11(1):e0145514. PubMed ID: 26752417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
    Borer JS; Böhm M; Ford I; Robertson M; Komajda M; Tavazzi L; Swedberg K;
    Am J Cardiol; 2014 Feb; 113(3):497-503. PubMed ID: 24332674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.
    Agostoni P; Corrà U; Cattadori G; Veglia F; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Mezzani A; Salvioni E; Scrutinio D; Ricci R; Bettari L; Di Lenarda A; Pastormerlo LE; Pacileo G; Vaninetti R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Confalonieri M; Giannuzzi P; Passantino A; Cas LD; Piepoli MF; Passino C;
    Int J Cardiol; 2013 Sep; 167(6):2710-8. PubMed ID: 22795401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.
    Seo HS; Jung YJ; Kim JH; Lee HH; Park CH
    Am J Clin Oncol; 2019 Dec; 42(12):909-917. PubMed ID: 31693512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients.
    Tsou YA; Chang WD; Lu JJ; Wu TF; Chen HL; Chen CM; Tsai MH
    BMC Cancer; 2019 Aug; 19(1):862. PubMed ID: 31470817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure.
    Retwiński A; Kosmalski M; Crespo-Leiro M; Maggioni A; Opolski G; Ponikowski P; Poloński L; Jankowska E; Drzewoski J; Drożdż J
    Kardiol Pol; 2018; 76(9):1336-1343. PubMed ID: 29862487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
    De Blois J; Simard S; Atar D; Agewall S;
    J Card Fail; 2010 Mar; 16(3):225-9. PubMed ID: 20206897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.
    Cooper LB; Mi X; Mentz RJ; Green JB; Anstrom KJ; Hernandez AF; Curtis LH
    Clin Cardiol; 2017 Jan; 40(1):38-45. PubMed ID: 27783884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.